Sage Journals: Discover world-class research

Open access

Research article

First published 2018-4

Landscape of MS patient cohorts and registries: Recommendations for maximizing impact

Bruce F Bebo, Robert J Fox, Karen Lee [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

Francesco Patti, Andrea Visconti, Antonio Capacchione [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2021-2

Data harmonization for collaborative research among MS registries: A case study in employment

A Salter, A Stahmann, D Ellenberger [...]

Multiple Sclerosis Journal

Retricted access

Brief report

First published 2020-1

Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France

Sandra Vukusic, Romain Casey, Fabien Rollot [...]

Multiple Sclerosis Journal

Retricted access

Editorial

First published 2014-10

How useful are MS registries?

Anthony Traboulsee, Katrina McMullen

Multiple Sclerosis Journal

Retricted access

Research article

First published 2019-10

Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry

Paulus Stefan Rommer, Kerstin Eichstädt, David Ellenberger [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-2

A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry

Jan Hillert, Jon A Tsai, Mona Nouhi [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-1

Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registry

Päivi Hämäläinen, Matias Viitala, Merja Soilu-Hänninen [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2024-06

Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry

Pavel Potuznik, Jiri Drahota, Dana Horakova [...]

Journal of Central Nervous System Disease

Retricted access

Research article

First published 2018-7

Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registry

Tim Spelman, Thomas Frisell, Fredrik Piehl [...]

Multiple Sclerosis Journal

Search results